Evidence map›Paper›PMID 31437198›Full record

ArticlePloS one2019

Primary care physicians' perceptions of barriers and facilitators to management of chronic kidney disease: A mixed methods study.

C John Sperati, Sandeep Soman, Varun Agrawal, Yang Liu, Khaled Abdel-Kader, Clarissa J Diamantidis, Michelle M Estrella, Kerri Cavanaugh, Laura Plantinga, Jane Schell and 6 more

Abstract readMulticenter Study
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Addressing Unmet Needs in the Management of Chronic Kidney Disease.International journal of general medicine · 2026
    Review
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Diabetes Educators: Understanding the Role of Finerenone in Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

C John SperatiDivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.ORCID 0000-0002-8409-0714
Sandeep SomanDivision of Nephrology, Henry Ford Hospital, Detroit, Michigan, United States of America.
Varun AgrawalDivision of Nephrology and Hypertension, University of Vermont College of Medicine, Burlington, Vermont, United States of America.
Yang LiuJohns Hopkins Medicine International, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America.
Khaled Abdel-KaderDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center; Vanderbilt Center for Kidney Disease, Nashville, Tennessee, United States of America.
Clarissa J DiamantidisDivisions of General Internal Medicine and Nephrology, Duke University School of Medicine, Durham, North Carolina, United States of America.ORCID 0000-0001-8212-6288
Michelle M EstrellaKidney Health Research Collaborative, Department of Medicine, University of California, San Francisco and San Francisco VA Health Care System, San Francisco, California, United States of America.
Kerri CavanaughDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center; Vanderbilt Center for Kidney Disease, Nashville, Tennessee, United States of America.
Laura PlantingaDepartment of Medicine, Emory University, Atlanta, Georgia, United States of America.
Jane SchellSection of Palliative Care and Medical Ethics, Division of Renal-Electrolyte, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.
James SimonDepartment of Nephrology and Hypertension, Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
Joseph A VassalottiIcahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Michael J ChoiDivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Bernard G JaarDivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Raquel C GreerThe Welch Center for Prevention, Epidemiology, and Clinical Research, Baltimore, Maryland, United States of America.
National Kidney Foundation Education Committee

Funding

Determining Key Organizational Health Communication Practices in Complex PatientsR01DK103935 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CAVANAUGH, KERRI · 2015 to 2019
$2.0M
Improving Primary Care to Narrow Racial Disparities in Chronic Kidney DiseaseK23DK094975 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI GREER, RAQUEL CHARLES · 2012 to 2015
$722k
NIDDK NIH HHS K23 DK094975NIDDK NIH HHS R01 DK103935
6 · The paper itself

Abstract

backgroundGiven the high prevalence of chronic kidney disease (CKD), primary care physicians (PCPs) frequently manage early stage CKD. Nonetheless, there are challenges in providing optimal CKD care in the primary care setting. This study sought to understand PCPs' perceptions of barriers and facilitators to the optimal management of CKD. STUDY

designMixed methods study. SETTINGS AND

participantsCommunity-based PCPs in four US cities: Baltimore, MD; St. Louis, MO; Raleigh, NC and San Francisco, CA. METHODOLOGY: We used a self-administered questionnaire and conducted 4 focus groups of PCPs (n = 8 PCPs/focus group) in each city to identify key barriers and facilitators to management of patients with CKD in primary care. ANALYTIC APPROACH: We conducted descriptive analyses of the survey data. Major themes were identified from audio-recorded interviews that were transcribed and coded by the research team.

resultsOf 32 participating PCPs, 31 (97%) had been in practice for >10 years, and 29 (91%) practiced in a non-academic setting. PCPs identified multiple barriers to managing CKD in primary care including at the level of the patient (e.g., low awareness of CKD, poor adherence to treatment recommendations), the provider (e.g., staying current with CKD guidelines), and the health care system (e.g., inflexible electronic medical record, limited time and resources). PCPs desired electronic prompts and lab decision support, concise guidelines, and healthcare financing reform to improve CKD care.

conclusionsPCPs face substantial but modifiable barriers in providing care to patients with CKD. Interventions that address these barriers and promote facilitative tools may improve PCPs' effectiveness and capacity to care for patients with CKD.

Indexed as

Attitude of Health PersonnelDisease ManagementCitiesCommunication BarriersFemaleFocus GroupsHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPatient CompliancePhysicians, Primary CarePractice Guidelines as TopicPractice Patterns, Physicians'Renal Insufficiency, ChronicSurveys and Questionnaires

Identifiers

PMID31437198
PMCPMC6705804

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.